, Tracking Stock Market Picks
Enter Symbol:
AbbVie (ABBV) [hlAlert]

up 44.34 %

AbbVie (ABBV) upgraded to Outperform by Credit Suisse

Posted on: Wednesday,  Oct 9, 2013  8:25 AM ET by Credit Suisse

Credit Suisse rated Outperform AbbVie (NYSE: ABBV) on 10/09/2013, when the stock price was $44.69. Since
then, AbbVie has gained 44.35% as of 12/01/2015's recent price of $64.51.
If you would have followed this Credit Suisse's recommendation on ABBV, you would have gained 44.34% of your investment in 783 days.

Excellence in equity and fixed income research is a hallmark of Credit Suisse. Globally, our equity research analysts provide in-depth coverage of over 2,500 companies and engage in a knowledge-sharing, value added culture that has yielded the most insightful product for our customers and tremendous competitive results. Additionally, Credit Suisse's powerful macro-economic and debt strategy teams integrate the bank's comprehensive company research with keen market perspectives of the ever-shifting investment terrain.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/9/2013 8:25 AM Buy
as of 12/13/2013
1 Week up  1.98 %
1 Month up  9.44 %
3 Months up  17.18 %
1 YTD up  17.18 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/7/2013 8:25 AM Hold

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy